Stay updated on Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.

Latest updates to the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page
- Check3 days agoChange DetectedAdded a general 'Locations' section and explicitly listed Massachusetts as a location; removed the previously listed 'Massachusetts Locations' entry. Updated the site footer by removing the 'HHS Vulnerability Disclosure' link and changed the page revision to v3.3.3.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no other content changes to the study details were observed.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the banner about a lapse in government funding and potential delays in updates. This site-wide notice is not part of the study details.SummaryDifference0.4%

- Check53 days agoChange DetectedNo significant updates detected to the study details page between the two screenshots. The content and structure appear unchanged.SummaryDifference0.5%

- Check81 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference3%

- Check88 days agoChange DetectedTerminology updated to a preferred form, and software version bumped from v3.0.2 to v3.1.0.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.